News

Amazon S3 on MSN11d
What is Advanced (Proliferative) Diabetic Retinopathy and Pars Plana Vitrectomy?
Dr. Michael Kapusta, MD, FRSCS, Ophthalmologist, talks about advanced (proliferative) diabetic retinopathy and pars plana ...
GlobalData on MSN11d
First subject dosed in Vantage’s Phase II trial for diabetic retinopathy
Vantage Biosciences has dosed the first subject in the randomised Phase II trial of oral therapy VX-01 to treat ...
Yahoo Finance15d
Vantage Biosciences Doses First Patient in Phase 2 Clinical Study of Oral VX-01 for Non-Proliferative Diabetic Retinopathy
an oral therapy for the treatment of non-proliferative diabetic retinopathy (NPDR). Diabetic retinopathy affects more than 100 million people worldwide and is one of the leading causes of ...
Ophthalmology Times8d
Effect of race on visual outcomes in DME treated with ranibizumab
The research team noted that racial subgroups are underrepresented in clinical trials, a factor that should be addressed in ...
American Association of Individual Investors4d
Why Ocular Therapeutix, Inc.’s (OCUL) Stock Is Up 6.02%
Ocular Therapeutix, Inc.’s OCUL share price has surged by 6.02%, which has investors questioning if this is right time to ...
American Association of Individual Investors5d
Why EyePoint Pharmaceuticals, Inc.’s (EYPT) Stock Is Up 6.87%
EyePoint Pharmaceuticals, Inc.’s EYPT share price has surged by 6.87%, which has investors questioning if this is right time ...
Endocrinology Advisor8d
HbA1c Level Before Cataract Surgery May Not Influence Endophthalmitis Risk
Patients with diabetes may not need to have a HbA1c value lower than 8% before cataract surgery to reduce the risk for endophthalmitis.